Sprout CEO on FDA’s approval of women’s sex drug Addyi

Health


Sprout CEO on FDA’s approval of women’s sex drug Addyi – CBS News


Watch CBSN Live



The FDA is giving the green light to flibanserin, the first prescription medication for women’s sexual dysfunction. First on “CBS This Morning,” Sprout Pharmaceuticals CEO Cindy Whitehead joins the show to discuss the pink pill that her company will market under the brand name “Addyi.”

Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.




Source link

Leave a Reply

Your email address will not be published. Required fields are marked *